View Older Stories View More Recent Stories

Oct 2, 2025 03:33PM FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-TAJS for extensive-stage small cell lung cancer
Sep 23, 2025 04:04PM Jazz Pharmaceuticals (JAZZ) PT Raised to $167 at Morgan Stanley
Sep 22, 2025 07:45AM Jazz Pharmaceuticals presents Xywav data at medical conferences
Sep 15, 2025 08:29AM Piper Sandler Reiterates Overweight Rating on Jazz Pharmaceuticals (JAZZ)
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Sep 9, 2025 07:45AM Jazz Pharmaceuticals' Modeyso added to NCCN cancer guidelines
Aug 28, 2025 09:25AM Jazz Pharmaceuticals (JAZZ) PT Raised to $205 at Truist Securities
Aug 28, 2025 08:54AM Jazz Pharmaceuticals (JAZZ) PT Raised at RBC Capital on 'Meaningful Upside' Potential
Aug 28, 2025 07:36AM Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Aug 20, 2025 07:30AM Jazz Pharmaceuticals licenses epilepsy drug from Saniona for $42.5M
Aug 14, 2025 06:14AM Jazz Pharmaceuticals (JAZZ) PT Raised to $225 at BofA Securities
Aug 6, 2025 02:24PM FDA approves Jazz Pharmaceuticals' dordaviprone for rare brain cancer
Aug 5, 2025 04:29PM Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 63c
Jul 15, 2025 04:05AM Deutsche Bank Starts Jazz Pharmaceuticals (JAZZ) at Buy
Jul 10, 2025 07:30AM Jazz Pharmaceuticals names Renee Gala as CEO, Bruce Cozadd to retire
Jul 1, 2025 08:32AM Jazz Pharmaceuticals (JAZZ) Receives EU Marketing Authorization for Ziihera
Jun 11, 2025 07:15AM Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Jun 10, 2025 07:05AM Jazz Pharmaceuticals (JAZZ) Reports Zepzelca and Atezolizumab Combination Granted FDA Priority Review
Jun 9, 2025 06:27PM Jazz Pharmaceuticals (JAZZ) presents phase 4 Xywav data
Jun 3, 2025 08:19AM UBS Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Jun 2, 2025 04:05PM Jazz Pharmaceuticals (JAZZ) Announces Zepzelca and Atezolizumab Combination Significantly Improves Survival as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Jun 2, 2025 12:38PM Jazz Pharmaceuticals (JAZZ) Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera in mGEA
May 25, 2025 03:00PM Biotech stocks Q1 earnings review
May 6, 2025 04:30PM Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 313c; offers guidance
Apr 22, 2025 09:34AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Apr 21, 2025 04:05PM Jazz Pharmaceuticals (JAZZ) Completes Acquisition of Chimerix
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 05:26AM BofA on Jazz Pharmaceuticals (JAZZ): 'sell-off looks overblown'
Apr 8, 2025 10:19AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $166 at UBS
Mar 13, 2025 06:58AM Cantor Biotech industry report, buying value in RevGens
Mar 11, 2025 06:41AM Jazz Pharmaceuticals (JAZZ) PT Raised to $217 at H.C. Wainwright
Mar 7, 2025 05:03AM UBS Upgrades Jazz Pharmaceuticals (JAZZ) to Buy
Mar 6, 2025 07:37AM Jazz Pharmaceuticals (JAZZ) PT Raised to $230 at Truist Following Chimerix Acquisition
Mar 5, 2025 07:02AM JAZZ (JAZZ) to Acquire Chimerix (CMRX) for $8.55/sh Cash
Feb 26, 2025 09:43AM Jazz Pharmaceuticals (JAZZ) PT Lowered at RBC as 'Lighter Pipeline Puts Commercial Execution in Spotlight'
Feb 26, 2025 07:39AM Jazz Pharmaceuticals (JAZZ) PT Raised to $210 at Needham
Feb 25, 2025 04:06PM Jazz Pharmaceuticals (JAZZ) Tops Q4 EPS by 81c, provides guidance
Feb 6, 2025 05:35PM Jazz Pharmaceuticals Joins the Movement for Awareness and Support on World Cancer Day with The Upside Down Challenge
Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Dec 17, 2024 10:08AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ) Following CEO Transition Plan Announcement
Dec 16, 2024 04:05PM Jazz Pharmaceuticals (JAZZ) Announces CEO Change
Dec 16, 2024 04:54AM Jazz Pharmaceuticals (JAZZ) PT Raised to $220 at Truist Securities
Dec 12, 2024 07:53AM Morgan Stanley Upgrades Jazz Pharmaceuticals (JAZZ) to Overweight
Dec 12, 2024 07:36AM Piper Sandler Reiterates Overweight Rating on Jazz Pharmaceuticals (JAZZ); Awaiting GEA Data for Ziihera
Dec 11, 2024 07:35AM Piper Sandler Provides 'Expert Perspectives On Orexin Agonists And An Evolving Sleep/Wake Space'
Dec 5, 2024 07:46AM Jazz Pharmaceuticals (JAZZ) Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii
Nov 21, 2024 10:24AM Jazz Pharmaceuticals (JAZZ) PT Raised to $160 at Jefferies
Nov 21, 2024 07:46AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Nov 21, 2024 07:09AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $163 at Piper Sandler
Nov 20, 2024 07:24PM Jazz Pharmaceuticals (JAZZ) Announces FDA Approval of Ziiher
View More Recent Stories View Older Stories